Blogs

Blogs

ASCOconnection.org is a forum for the exchange of views on topical issues in the field of oncology. The views expressed in the blogs, comments, and forums belong to the authors. They do not necessarily reflect the views or positions of the American Society of Clinical Oncology. Please read the Commenting Guidelines.

No Results.

We personalize cancer treatment for our patients. Perhaps it is time to personalize how we acknowledge the transitions in their cancer experience.
Dr. Margaret Kemeny and colleagues at Queens Cancer Center deliver high-quality care to patients whose primary concern may not be their cancer.
The patients we mentally label as "difficult" are perhaps the ones who need our empathy the most.
On Christmas morning, I had to tell my beloved father in law that he was dying. 
Dr. Narjust Duma documents her journey through different phases of grief and gratitude as a special patient transfers to hospice care.
The concept of overdiagnosis must be communicated accurately and in a culturally sensitive way, writes Dr. Aju Mathew. 
Dr. Marcia Cruz-Correa describes the cancer care landscape in Puerto Rico and the discussions that took place in San Juan and Caguas as part of ASCO's ongoing town hall series.
Wherever we practice, none of us need to look very far to find people who, through no fault of their own, are living right on the knife’s edge of disaster.
Dr. Ashley Sumrall fulfilled a dream of performing in the famous Carnegie Hall, and discovered that the practice, teamwork, and commitment required onstage paralleled her work in oncology.
It's hard enough to try dating again after a cancer diagnosis and treatment, but some of my patients also face strong opposition from their adult children.
Dr. Suneel D. Kamath was surprised to learn how important laughter and levity can be in the physician-patient relationship.
When a patient asks, "Why me?", Dr. Stephanie Graff considers that they may not be asking for a list of their cancer risk factors.
Predictive analytics, complex treatment pathways, tele-oncology, and more: Dr. Robert M. Daly identifies five trends that are poised to disrupt oncology practice in the coming year.
Immunotherapy—particularly immune checkpoint inhibition—is still experimental. It ends up being quite a difficult discussion for some who had hoped that they could stave off chemotherapy.
One of my most challenging clinical experiences is trying to counsel a patient whose preferred treatment is a literal miracle. 
Dr. Pesona Grace Lucksom's career journey has been shaped by a series of battles with hormones and their impact on women's health, and this is a fight she intends to win.
A deliberately stylish patient led me to wonder if any insight can be gleaned from our patients' clothing choices as a reflection of how they're navigating the experience of illness and recovery.
My patient's greatest fear was living in pain, so I called on my incredible colleagues in palliative care.

Pages


Advertisement